Sargramostim (rhu GM-CSF) and Immune Checkpoint Inhibitors : Combinatorial Therapeutic Studies in Metastatic Melanoma(Post)
Metastatic melanoma presents significant treatment challenges, but advancements in immunotherapy, particularly the combination of Sargramostim (rhu GM-CSF) and immune checkpoint inhibitors, offer pr ...
Product results
Product results
- Product
- Qty in Cart
- Quantity
- Price
- Subtotal
-
£388.96 -
SHIKARI Q-PEM (Pembrolizumab) ELISA | 30137260
£1,743.46SHIKARI Q-PEM (Pembrolizumab) ELISA | 30137260 | IBL International Application: ELISA Category Type: Immunology181-30137260£1,743.46 -
SHIKARI S-ATP (Anti-Pembrolizumab Ab) ELISA | 30137262
£1,743.46SHIKARI S-ATP (Anti-Pembrolizumab Ab) ELISA | 30137262 | IBL International Application: ELISA Category Type: Immunology181-30137262£1,743.46 -
pHR_Gal4UAS_Pembrolizumab_heavychain_T2A_ Pembrolizumab_lightcha
£304.30Order pHR_Gal4UAS_Pembrolizumab_heavychain_T2A_ Pembrolizumab_lightcha from Nova Lifetech / Life Science Market by email to eu@genprice.comPVT11019£304.30